Physician profile
Edward Murphy
NPI 1154408144
$2,038.02
in general payments reported to CMS, 2019-2025
8 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.86 · 2020: $112 · 2022: $265 · 2023: $376 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936 · Travel and Lodging: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.94 |
| Travel and Lodging | $673.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $992.82 | 2025 | Myspine, Mecta-C, Must |
| Abbott Laboratories | $311.23 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Biogen, INC. | $180.13 | 2023-2025 | Spinraza, Spinraza |
| Davol INC. | $156.43 | 2025 | Arista |
| Nevro Corp. | $132.08 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $111.95 | 2020 | |
| Glaxosmithkline, LLC. | $101.52 | 2023 | Bexsero |
| Stryker Corporation | $51.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.